Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT – Get Free Report) has earned an average rating of “Hold” from the five brokerages that are presently covering the firm, Marketbeat reports. One analyst has rated the stock with a sell recommendation, one has issued a hold recommendation and three have assigned a buy recommendation to the company. The average 12-month price target among brokers that have issued a report on the stock in the last year is $21.40.
A number of equities research analysts have recently weighed in on the stock. Wells Fargo & Company cut their target price on shares of Calumet Specialty Products Partners from $29.00 to $28.00 and set an “overweight” rating on the stock in a research note on Wednesday. StockNews.com raised shares of Calumet Specialty Products Partners to a “sell” rating in a research note on Monday, November 18th. HC Wainwright reissued a “buy” rating and set a $33.00 price objective on shares of Calumet Specialty Products Partners in a research note on Monday. UBS Group lowered shares of Calumet Specialty Products Partners from a “neutral” rating to a “sell” rating and dropped their price objective for the stock from $20.50 to $15.00 in a research note on Tuesday, February 4th. Finally, TD Cowen lowered shares of Calumet Specialty Products Partners from a “buy” rating to a “hold” rating and dropped their price objective for the stock from $26.00 to $16.00 in a research note on Tuesday.
Get Our Latest Research Report on CLMT
Insider Transactions at Calumet Specialty Products Partners
Calumet Specialty Products Partners Trading Down 0.5 %
Shares of CLMT opened at $12.98 on Friday. The firm’s 50-day moving average price is $17.83 and its 200-day moving average price is $19.20. The firm has a market capitalization of $1.12 billion, a price-to-earnings ratio of -4.70 and a beta of 1.88. Calumet Specialty Products Partners has a 1-year low of $9.97 and a 1-year high of $25.29.
Calumet Specialty Products Partners (NASDAQ:CLMT – Get Free Report) last announced its earnings results on Friday, February 28th. The oil and gas company reported ($0.47) earnings per share for the quarter, beating analysts’ consensus estimates of ($1.06) by $0.59. The company had revenue of $949.50 million for the quarter, compared to the consensus estimate of $921.76 million. The company’s revenue for the quarter was down 2.8% on a year-over-year basis. During the same period in the previous year, the firm posted ($0.59) EPS. On average, research analysts forecast that Calumet Specialty Products Partners will post -3.02 EPS for the current fiscal year.
Calumet Specialty Products Partners Company Profile
Calumet, Inc engages in the manufacturing, formulating, and marketing of a diversified slate of specialty branded products and renewable fuels to customers across a broad range of consumer-facing and industrial markets. It operates through the following segments: Specialty Products & Solutions, Performance Brands, Montana/Renewables, and Corporate.
Recommended Stories
- Five stocks we like better than Calumet Specialty Products Partners
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Corporate Crawl: Where Business Trips Turn Into Party Nights
- Investing in the High PE Growth Stocks
- CrowdStrike’s Growth Remains Strong—Buy While It’s Down
- How is Compound Interest Calculated?
- Is Advanced Micro Devices Stock Slide Over?
Receive News & Ratings for Calumet Specialty Products Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calumet Specialty Products Partners and related companies with MarketBeat.com's FREE daily email newsletter.